Breast cancer patients harbouring a methylated ID4 promoter were found to have a decreased mean RFS time in comparison to patients without ID4 methylation in the tumour, supporting the hypothesis that a functional ID4 gene indeed confers tumour suppressive functions to human breast tissue. The gene discussed is ID4; the disease is neoplasm.